<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20130603013568N7</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-02-13</date_registration>
      <primary_sponsor>Kermanshah University of Medical Sciences</primary_sponsor>
      <public_title>The Effect of Multimedia Education on Anxiety and Pain in Patients Undergoing Laparoscopic Gallbladder Removal</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the Effect of Multimedia Education on Anxiety and Pain in Patients Undergoing Laparoscopic Cholecystectomy</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-04-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>80</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/68392</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Other design features: In the present study, Solomon four-group design will be used. In this way, patients are randomly assigned to four groups (two intervention groups (which will receive multimedia education) and two control groups (which will receive routine care)). In one of the intervention groups, before the intervention, a pre-test (measurement of state and trait anxiety) will be performed, but in the other intervention group, the pre-test will not be performed (anxiety level will not be measured before receiving the intervention). Regarding the control groups, it will be done in the same way; in one of the control groups a pre-test will be done, but not in the other group. The post-test (measurement of anxiety on the day of surgery (before entering the operating room) and also 24 hours after surgery will be performed in all four groups. In addition, hemodynamic parameters will be measured the day before surgery, the day of surgery (before entering the operating room) and 24 hours after surgery in the four groups, Randomization description: Simple randomization will be used and the random sequence generation tool will be statistical software. Patients are randomly assigned to four groups (two intervention groups (one group with a pre-test and another without a pre-test) (20 patients in each intervention group) and two control groups (one group with a pre-test and another without a pre-test) (20 patients in each control group)). For this purpose, the 80 numbers generated by the software are written on 80 cards, and in order to conceal the allocation, the cards will be placed in sealed opaque envelopes. Odd numbers will be considered for the intervention groups and even numbers for the control groups.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Cholelithiasis. Condition 2: Cholecystitis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In the intervention groups (intervention group with pre-test and intervention group without pre-test) the day before the surgery, multimedia education will be done for 30 minutes. In the group with pre-test, first, the patient's anxiety level is measured using Spielberger State-Trait Anxiety Inventory scale, as well as hemodynamic parameters, and then the intervention is performed. In the other intervention group, the pre-test will not be performed before receiving the intervention, but hemodynamic parameters will be measured. Intervention: explanations about the function of gallbladder, cholelithiasis and cholecystitis, risk factors and pathophysiology of these diseases, the benefits of laparoscopic cholecystectomy compared to open surgery is presented to patients in the form of a video, and pamphlets related to the mentioned items are provided to them, and operating room and recovery room pictures will be shown. Then explanations about general anesthesia, drugs used for this purpose and complications of general anesthesia are presented to them, followed by the injection of anesthetic drugs by an anesthesiologist, as well as how intubation is done and tools used in this procedure, including laryngoscope and tracheal tube, in the form of a video, and the pictures of these tools will be shown to them. The surgical team, including the surgeon, assistant surgeon, scrub nurse, circulator nurse and anesthesia expert, and their duties are explained to the patient, and a video about preparing the surgical instruments, the surgical bed, and disinfecting the surgical site is shown to the patient. Information about the surgery, including creating three holes in the abdomen, blowing carbon dioxide gas, and then performing sutures and placing a hemovac drain, and the duration of the surgery is provided to the patients in a video, and the pictures related to the location of the sutures are shown to them. Postoperative complications and the care provided in the ward until discharge including drugs, drain, dressings, the duration of not receiving anything by mouth (the duration of being NPO (nothing by mouth)) and not leaving the bed and the length of stay in the hospital is presented to the patients in the form of a video and pamphlets related to these items are provided to them. Then, the method of doing breathing exercises to reduce the patient's pain is explained in a video and a pamphlet containing this information is provided to them. The intervention groups will also receive usual care. In order to assess the content validity of the prepared educational package, the educational content will be provided to 12 experts. To display videos and photos, smartphone will be used. Intervention 2: Control group: There will be no intervention in the control groups (control group with pre-test and control group without pre-test). In the control group with pre-test, the day before surgery, the patient's anxiety level will be measured using Spielberger State-Trait Anxiety Inventory scale, as well as hemodynamic parameters, but in the other group, only hemodynamic parameters will be measured the day before surgery. These two groups only receive routine care, including heart consultation, anesthesia consultation, informed consent, which includes information such as the advantages of the proposed method, alternative methods, disadvantages of the proposed method, comparison of the proposed and alternative methods in terms of advantages and disadvantages, and the risk level of the proposed method, necessary laboratory tests, shaving and marking the surgical site and not receiving anything by mouth (being NPO (nothing by mouth)) before the surgery.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is For keeping anonymous</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Narges Sadeghi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Molavi Alley,  Shahid Bagheri Blvd</address>
        <city>Eslamabad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6761111413</zip>
        <telephone>+98 83 4522 8754</telephone>
        <email>narges.sadeghi7799@gmail.com</email>
        <affiliation>Kermanshah University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Rostam Jalali</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Nursing Department, Faculty of Nursing and Midwifery, Dolat Abad Blvd</address>
        <city>Kermanshah</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6719816593</zip>
        <telephone>+98 83 3724 6613</telephone>
        <email>ks_jalali@yahoo.com</email>
        <affiliation>Kermanshah University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Willingness to participate in the study
Patients at the age of 18-65 years old
Being able to communicate
Having no severe vision and hearing problems
Being able to read and write
No history of abdominal surgery</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Drug addiction
Use of sedative medications
Having psychological disorders
Having respiratory diseases such as asthma and chronic obstructive pulmonary disease</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>K80</hc_code>
      <hc_code>K81</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Cholelithiasis</hc_keyword>
      <hc_keyword>Cholecystitis</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In the intervention groups (intervention group with pre-test and intervention group without pre-test) the day before the surgery, multimedia education will be done for 30 minutes. In the group with pre-test, first, the patient's anxiety level is measured using Spielberger State-Trait Anxiety Inventory scale, as well as hemodynamic parameters, and then the intervention is performed. In the other intervention group, the pre-test will not be performed before receiving the intervention, but hemodynamic parameters will be measured. Intervention: explanations about the function of gallbladder, cholelithiasis and cholecystitis, risk factors and pathophysiology of these diseases, the benefits of laparoscopic cholecystectomy compared to open surgery is presented to patients in the form of a video, and pamphlets related to the mentioned items are provided to them, and operating room and recovery room pictures will be shown. Then explanations about general anesthesia, drugs used for this purpose and complications of general anesthesia are presented to them, followed by the injection of anesthetic drugs by an anesthesiologist, as well as how intubation is done and tools used in this procedure, including laryngoscope and tracheal tube, in the form of a video, and the pictures of these tools will be shown to them. The surgical team, including the surgeon, assistant surgeon, scrub nurse, circulator nurse and anesthesia expert, and their duties are explained to the patient, and a video about preparing the surgical instruments, the surgical bed, and disinfecting the surgical site is shown to the patient. Information about the surgery, including creating three holes in the abdomen, blowing carbon dioxide gas, and then performing sutures and placing a hemovac drain, and the duration of the surgery is provided to the patients in a video, and the pictures related to the location of the sutures are shown to them. Postoperative complications and the care provided in the ward until discharge including drugs, drain, dressings, the duration of not receiving anything by mouth (the duration of being NPO (nothing by mouth)) and not leaving the bed and the length of stay in the hospital is presented to the patients in the form of a video and pamphlets related to these items are provided to them. Then, the method of doing breathing exercises to reduce the patient's pain is explained in a video and a pamphlet containing this information is provided to them. The intervention groups will also receive usual care. In order to assess the content validity of the prepared educational package, the educational content will be provided to 12 experts. To display videos and photos, smartphone will be used.</i_keyword>
      <i_keyword>Control group: There will be no intervention in the control groups (control group with pre-test and control group without pre-test). In the control group with pre-test, the day before surgery, the patient's anxiety level will be measured using Spielberger State-Trait Anxiety Inventory scale, as well as hemodynamic parameters, but in the other group, only hemodynamic parameters will be measured the day before surgery. These two groups only receive routine care, including heart consultation, anesthesia consultation, informed consent, which includes information such as the advantages of the proposed method, alternative methods, disadvantages of the proposed method, comparison of the proposed and alternative methods in terms of advantages and disadvantages, and the risk level of the proposed method, necessary laboratory tests, shaving and marking the surgical site and not receiving anything by mouth (being NPO (nothing by mouth)) before the surgery.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>State anxiety score in Spielberger State-Trait Anxiety Inventory scale. Timepoint: At the beginning of the study (before the intervention, the day before surgery) in two of the four groups (one of the intervention groups and one of the control groups), the day of surgery before entering the operating room in all four groups and 24 hours after surgery in all four groups. Method of measurement: Spielberger State-Trait Anxiety Inventory scale.</prim_outcome>
      <prim_outcome>Trait anxiety score in Spielberger State-Trait Anxiety Inventory scale. Timepoint: At the beginning of the study (before the intervention, the day before surgery) in two of the four groups (one of the intervention groups and one of the control groups), the day of surgery before entering the operating room in all four groups and 24 hours after surgery in all four groups. Method of measurement: Spielberger State-Trait Anxiety Inventory scale.</prim_outcome>
      <prim_outcome>Pain intensity in Visual Analogue Scale. Timepoint: 24 hours after surgery in all four groups. Method of measurement: Visual Analogue Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Hemodynamic parameters (heart rate). Timepoint: At the beginning of the study (before the intervention, the day before surgery) in the four groups, the day of surgery before entering the operating room in all four groups and 24 hours after surgery in all four groups. Method of measurement: Using a pulse oximeter.</sec_outcome>
      <sec_outcome>Hemodynamic parameters (systolic blood pressure). Timepoint: At the beginning of the study (before the intervention, the day before surgery) in the four groups, the day of surgery before entering the operating room in all four groups and 24 hours after surgery in all four groups. Method of measurement: Using a blood pressure device.</sec_outcome>
      <sec_outcome>Hemodynamic parameters (diastolic blood pressure). Timepoint: At the beginning of the study (before the intervention, the day before surgery) in the four groups, the day of surgery before entering the operating room in all four groups and 24 hours after surgery in all four groups. Method of measurement: Using a blood pressure device.</sec_outcome>
      <sec_outcome>Hemodynamic parameters (Arterial blood oxygen saturation level). Timepoint: At the beginning of the study (before the intervention, the day before surgery) in the four groups, the day of surgery before entering the operating room in all four groups and 24 hours after surgery in all four groups. Method of measurement: Using a pulse oximeter.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Kermanshah University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-01-24</approval_date>
        <contact_name>Ethics committee of Kermanshah University of Medical Sciences</contact_name>
        <contact_address>Deputy of Research and Technology, No. 2 Building, Kermanshah University of Medical Sciences, Shahid Beheshti Blvd, Kermanshah Kermanshah Kermanshah Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
